文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

可溶性 CD14、缺血性卒中和前瞻性研究中的冠心病风险:REGARDS 队列研究。

Soluble CD14, Ischemic Stroke, and Coronary Heart Disease Risk in a Prospective Study: The REGARDS Cohort.

机构信息

Department of Pathology and Laboratory Medicine Larner College of Medicine University of Vermont Burlington VT.

Department of Epidemiology University of Washington Seattle WA.

出版信息

J Am Heart Assoc. 2020 Mar 17;9(6):e014241. doi: 10.1161/JAHA.119.014241. Epub 2020 Mar 11.


DOI:10.1161/JAHA.119.014241
PMID:32157955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7335508/
Abstract

Background Soluble CD14 (sCD14), a circulating pattern recognition receptor, has been suggested as a cardiovascular disease risk factor. Prospective studies evaluating sCD14 with incident cardiovascular disease events are limited, particularly among racially diverse populations. Methods and Results Between 2003 and 2007, the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study recruited 30 239 black and white participants across the United States. In a nested case-cohort study, sCD14 was measured in baseline serum from 548 cases of incident ischemic stroke, 612 cases of incident coronary heart disease (CHD), and a cohort random sample (n=1039). Cox models estimated hazards ratios (HR) of incident ischemic stroke or CHD per 1 SD higher sCD14, adjusting for cardiovascular disease risk factors. There was a differential association of sCD14 with ischemic stroke and CHD risk by race. Among blacks, the adjusted HR of stroke per SD increment of sCD14 was 1.42 (95% CI: 1.12, 1.80), with no association among whites (HR 1.02 [95% CI: 0.82, 1.27]). Higher sCD14 was associated with increased CHD risk in blacks but not whites, and relationships between sCD14 and CHD were stronger at younger ages. Adjusted for risk factors, the HR of CHD per SD higher sCD14 among blacks at age 45 years was 2.30 (95% CI: 1.45, 3.65) compared with 1.56 (95% CI: 0.94, 2.57) among whites. At age 65 years, the CHD HR was 1.51 (95% CI: 1.20, 1.91) among blacks and 1.02 (95% CI: 0.80, 1.31) among whites. Conclusions sCD14 may be a race-specific stroke and CHD risk marker.

摘要

背景 可溶性 CD14(sCD14)是一种循环模式识别受体,被认为是心血管疾病的风险因素。评估 sCD14 与心血管疾病事件的前瞻性研究有限,特别是在不同种族的人群中。

方法和结果 在 2003 年至 2007 年期间,REGARDS(地理和种族差异中风原因)研究在美国各地招募了 30239 名黑人和白人参与者。在一项巢式病例对照研究中,548 例新发缺血性卒中、612 例新发冠心病(CHD)和队列随机样本(n=1039)的基线血清中检测了 sCD14。Cox 模型估计了 sCD14 每增加 1 个标准差时发生缺血性卒中或 CHD 的风险比(HR),并调整了心血管疾病危险因素。sCD14 与缺血性卒中和 CHD 风险的相关性在不同种族之间存在差异。在黑人中,sCD14 每增加 1 个标准差,卒中的调整后 HR 为 1.42(95%CI:1.12,1.80),而白人中无相关性(HR 1.02[95%CI:0.82,1.27])。黑人中 sCD14 水平升高与 CHD 风险增加相关,但白人中无相关性,且 sCD14 与 CHD 之间的关系在较年轻时更强。调整危险因素后,黑人 45 岁时 sCD14 每增加 1 个标准差,CHD 的 HR 为 2.30(95%CI:1.45,3.65),而白人则为 1.56(95%CI:0.94,2.57)。黑人 65 岁时,CHD 的 HR 为 1.51(95%CI:1.20,1.91),而白人则为 1.02(95%CI:0.80,1.31)。

结论 sCD14 可能是一种种族特异性的卒中及 CHD 风险标志物。

相似文献

[1]
Soluble CD14, Ischemic Stroke, and Coronary Heart Disease Risk in a Prospective Study: The REGARDS Cohort.

J Am Heart Assoc. 2020-3-17

[2]
Associations of coagulation factors IX and XI levels with incident coronary heart disease and ischemic stroke: the REGARDS study.

J Thromb Haemost. 2017-6

[3]
D-dimer and the Risk of Stroke and Coronary Heart Disease. The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Thromb Haemost. 2017-2-28

[4]
Pro-neurotensin/neuromedin N and risk of ischemic stroke: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Vasc Med. 2020-12

[5]
Association of race and sex with risk of incident acute coronary heart disease events.

JAMA. 2012-11-7

[6]
Depressive symptoms are associated with incident coronary heart disease or revascularization among blacks but not among whites in the Reasons for Geographical and Racial Differences in Stroke study.

Ann Epidemiol. 2015-6

[7]
Risk of Incident Coronary Heart Disease Events in Men Compared to Women by Menopause Type and Race.

J Am Heart Assoc. 2015-7-1

[8]
Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS).

Thromb Haemost. 2018-6-11

[9]
Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study.

Cardiovasc Res. 2019-1-1

[10]
Hemoglobin levels and coronary heart disease risk by age, race, and sex in the reasons for geographic and racial differences in stroke study (REGARDS).

Am J Hematol. 2019-12-22

引用本文的文献

[1]
New cardiovascular disease markers in patients with familial hypercholesterolemia carriers of genetic variants.

J Diabetes Metab Disord. 2024-12-16

[2]
A Review of the Public Health Literature Examining the Roles of Socioeconomic Status and Race/Ethnicity on Health Outcomes in the United States.

J Racial Ethn Health Disparities. 2024-10-28

[3]
Synergy Between NK Cells and Monocytes in Potentiating Cardiovascular Disease Risk in Severe COVID-19.

Arterioscler Thromb Vasc Biol. 2024-10

[4]
Soluble CD14 and Incident Diabetes Risk: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

J Endocr Soc. 2024-5-23

[5]
Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis.

Int J Mol Sci. 2023-9-20

[6]
LDL associates with pro-inflammatory monocyte subset differentiation and increases in chemokine receptor profile expression in African Americans.

Int J Cardiol. 2022-7-1

[7]
Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study.

Res Pract Thromb Haemost. 2021-12-7

[8]
Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.

Arterioscler Thromb Vasc Biol. 2021-6

[9]
Search for Reliable Circulating Biomarkers to Predict Carotid Plaque Vulnerability.

Int J Mol Sci. 2020-11-3

本文引用的文献

[1]
Protein Biomarkers of Cardiovascular Disease and Mortality in the Community.

J Am Heart Assoc. 2018-7-13

[2]
Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.

Thromb Haemost. 2017-7-26

[3]
Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men.

J Infect Dis. 2017-5-1

[4]
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Circulation. 2017-3-7

[5]
Systemic Inflammation in Midlife: Race, Socioeconomic Status, and Perceived Discrimination.

Am J Prev Med. 2017-1

[6]
Genetic association between inflammatory genes (IL-1α, CD14, LGALS2, PSMA6) and risk of ischemic stroke: A meta-analysis.

Meta Gene. 2016-1-19

[7]
Inflammation and hemostasis in atrial fibrillation and coronary heart disease: The REasons for Geographic And Racial Differences in Stroke study.

Atherosclerosis. 2015-11

[8]
Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.

Clin J Am Soc Nephrol. 2015-9-4

[9]
Fibroblast growth factor 23 and risk of incident stroke in community-living adults.

Stroke. 2015-2

[10]
Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection.

J Infect Dis. 2015-4-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索